Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38369589)

  • 1. TRIP6 a potential diagnostic marker for colorectal cancer with glycolysis and immune infiltration association.
    Liu XS; Chen YX; Wan HB; Wang YL; Wang YY; Gao Y; Wu LB; Pei ZJ
    Sci Rep; 2024 Feb; 14(1):4042. PubMed ID: 38369589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIP6, as a target of miR-7, regulates the proliferation and metastasis of colorectal cancer cells.
    Ling Y; Cao C; Li S; Qiu M; Shen G; Chen Z; Yao F; Chen W
    Biochem Biophys Res Commun; 2019 Jun; 514(1):231-238. PubMed ID: 31029422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of an immune predictive model and identification of TRIP6 as a prognostic marker and therapeutic target of CRC by integration of single-cell and bulk RNA-seq data.
    Liu W; Luo X; Zhang Z; Chen Y; Dai Y; Deng J; Yang C; Liu H
    Cancer Immunol Immunother; 2024 Mar; 73(4):69. PubMed ID: 38430268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TTPAL Promotes Colorectal Tumorigenesis by Stabilizing TRIP6 to Activate Wnt/β-Catenin Signaling.
    Gou H; Liang JQ; Zhang L; Chen H; Zhang Y; Li R; Wang X; Ji J; Tong JH; To KF; Sung JJY; Chan FKL; Fang JY; Yu J
    Cancer Res; 2019 Jul; 79(13):3332-3346. PubMed ID: 31018940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIP6 regulates p27 KIP1 to promote tumorigenesis.
    Lin VT; Lin VY; Lai YJ; Chen CS; Liu K; Lin WC; Lin FT
    Mol Cell Biol; 2013 Apr; 33(7):1394-409. PubMed ID: 23339869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIP6: an adaptor protein that regulates cell motility, antiapoptotic signaling and transcriptional activity.
    Lin VT; Lin FT
    Cell Signal; 2011 Nov; 23(11):1691-7. PubMed ID: 21689746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of TRIP6-dependent nasopharyngeal cancer cell migration.
    Fei J; Li J; Shen S; Zhou W
    Tumour Biol; 2013 Aug; 34(4):2329-35. PubMed ID: 23576104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Expression Level of TRIP6 is Correlated with Poor Prognosis in Colorectal Cancer and Promotes Tumor Cell Proliferation and Migration.
    Ren H; Su Z; Yang J; Cao J; Zhang Y; Sheng K; Guo K; Wang Y
    Biochem Genet; 2024 Mar; ():. PubMed ID: 38430448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIP6 functions in brain ciliogenesis.
    Shukla S; Haenold R; Urbánek P; Frappart L; Monajembashi S; Grigaravicius P; Nagel S; Min WK; Tapias A; Kassel O; Heuer H; Wang ZQ; Ploubidou A; Herrlich P
    Nat Commun; 2021 Oct; 12(1):5887. PubMed ID: 34620853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the role of TRIP6 in cell physiology and cancer.
    Willier S; Butt E; Richter GH; Burdach S; Grunewald TG
    Biol Cell; 2011 Dec; 103(12):573-91. PubMed ID: 22054418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIP6 promotes tumorigenic capability through regulating FOXC1 in hepatocellular carcinoma.
    Wang F; Zhang B; Xu X; Zhu L; Zhu X
    Pathol Res Pract; 2020 Apr; 216(4):152850. PubMed ID: 32046874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIP6 accelerates the proliferation and invasion of cervical cancer by upregulating oncogenic YAP signaling.
    Yang F; Li L; Zhang J; Zhang J; Yang L
    Exp Cell Res; 2020 Nov; 396(1):112248. PubMed ID: 32853630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Zyxin-related protein thyroid receptor interacting protein 6 (TRIP6) is overexpressed in Ewing's sarcoma and promotes migration, invasion and cell growth.
    Grunewald TG; Willier S; Janik D; Unland R; Reiss C; Prazeres da Costa O; Buch T; Dirksen U; Richter GH; Neff F; Burdach S; Butt E
    Biol Cell; 2013 Nov; 105(11):535-47. PubMed ID: 24033704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor.
    Xu J; Lai YJ; Lin WC; Lin FT
    J Biol Chem; 2004 Mar; 279(11):10459-68. PubMed ID: 14688263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIP6, a novel molecular partner of the MAGI-1 scaffolding molecule, promotes invasiveness.
    Chastre E; Abdessamad M; Kruglov A; Bruyneel E; Bracke M; Di Gioia Y; Beckerle MC; van Roy F; Kotelevets L
    FASEB J; 2009 Mar; 23(3):916-28. PubMed ID: 19017743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of TRIP6 promotes tumor proliferation and reverses cell adhesion-mediated drug resistance (CAM-DR) via regulating nuclear p27(Kip1) expression in non-Hodgkin's lymphoma.
    Miao X; Xu X; Wu Y; Zhu X; Chen X; Li C; Lu X; Chen Y; Liu Y; Huang J; Wang Y; He S
    Tumour Biol; 2016 Jan; 37(1):1369-78. PubMed ID: 26298725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIP6 regulates neural stem cell maintenance in the postnatal mammalian subventricular zone.
    Lai YJ; Li MY; Yang CY; Huang KH; Tsai JC; Wang TW
    Dev Dyn; 2014 Sep; 243(9):1130-42. PubMed ID: 25044744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIP6 promotes cell proliferation in hepatocellular carcinoma via suppression of FOXO3a.
    Zhao W; Dai Y; Dai T; Xie T; Su X; Li J; Zhou X; Meng K; Zhao X
    Biochem Biophys Res Commun; 2017 Dec; 494(3-4):594-601. PubMed ID: 29080747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRIP6 and LPP, but not Zyxin, are present at a subset of telomeres in human cells.
    Sheppard SA; Savinova T; Loayza D
    Cell Cycle; 2011 Jun; 10(11):1726-30. PubMed ID: 21519191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Thyroid Receptor Interacting Protein 6 by MicroRNA-589-5p Inhibits Cell Proliferation, Migration, and Invasion in Endometrial Carcinoma.
    Wang Y; Dong L; Liu Y
    Cancer Biother Radiopharm; 2019 Oct; 34(8):529-536. PubMed ID: 31424277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.